Summary

Persistence Market Research has recently released a comprehensive report on the global Ophthalmic Packaging market. The report delivers an in-depth evaluation of key market dynamics-drivers, trends, opportunities, and restraints-while offering detailed insights into market structure, value chain evolution, and competitive positioning across regions.

Key Insights

- Ophthalmic Packaging Market Size (2026E): US$ 6.8 Bn
- Projected Market Value (2033F): US$ 19.7 Bn
- Global Market Growth Rate (CAGR 2026-2033): 16.4%

Ophthalmic Packaging Market - Report Scope

The ophthalmic packaging market report analyzes packaging solutions for eye care products across multiple formats including bottles, tubes, vials, ampoules, syringes, and specialized containers. It covers segmentation by dose format (single-dose and multi-dose), packaging type, materials (plastic and glass), and product categories (prescription and OTC). Regional analysis includes North America, Europe, and Asia Pacific markets with competitive landscape assessment.

Market Growth Drivers

Rising prevalence of eye disorders affecting 2.2 billion people globally with preventable vision impairment. Expanding aging population increasing consumption of ophthalmic medications and therapies. Growing demand for preservative-free formulations requiring advanced sterile packaging solutions. Increasing adoption of intravitreal injection therapies for diabetic macular edema and age-related macular degeneration.

Market Restraints

Stringent regulatory requirements demanding extensive material-formulation compatibility testing with approval cycles of 18-36 months. Rising production costs and raw material volatility with pharmaceutical-grade polymers accounting for up to 45% of costs. Limited manufacturing capacity for specialized materials like Type I borosilicate glass creating periodic supply shortages.

Market Opportunities

Rapid expansion of intravitreal injection therapies requiring specialized sterile vials, prefilled syringes, and integrated delivery devices. Growing OTC ophthalmic product consumption driven by dry eye disease affecting 290 million people and self-care adoption. Increasing demand for innovative consumer-friendly packaging emphasizing portability, ergonomics, and sustainability.

Key Questions Answered in the Report

- What are the major factors driving global demand for ophthalmic packaging?
- Which product segments and applications are fueling Ophthalmic Packaging market growth?
- How is North America - 38.4% shaping the Ophthalmic Packaging market landscape?
- Who are the leading players in the ophthalmic packaging market, and what strategies are they adopting?
- What are the emerging trends and long-term growth prospects for the global Ophthalmic Packaging market?

Competitive Intelligence and Business Strategy

Leading players in the ophthalmic packaging market are focusing on capacity expansion, product innovation, and strategic partnerships to strengthen their global footprint. Investments in advanced technologies and vertical integration help ensure consistent product quality and supply reliability. Companies are also prioritizing long-term customer relationships and geographic expansion, while emphasizing sustainability, operational efficiency, and cost optimization to gain a competitive edge.

Key Companies Profiled

- Gerresheimer AG
- AptarGroup Inc.
- Amcor plc
- Schott AG
- West Pharmaceutical Services Inc.
- Berry Global Inc.
- Bormioli Pharma S.p.A.
- Nolato AB
- Vetter Pharma
- SGD Pharma
- Tekni-Plex Inc.
- Recipharm AB
- ALPLA Group
- Hoffmann Neopac
- Nemera

Market Segmentation

By Dose Format
- Single-Dose
- Multi-Dose

By Packaging Type
- Bottles
- Tubes
- Vials & Ampoules
- Syringes/Pre-filled Syringes
- Other Ophthalmic Containers

By Material
- Plastic
- Glass
- Others

By Product Type
- Prescription Ophthalmic Products
- Over-the-Counter (OTC) Ophthalmic Products

By Region
- North America
- Europe
- East Asia
- South Asia & Oceania
- Latin America
- Middle East & Africa

ページTOPに戻る

Table of Contents

1. Executive Summary
1.1. Global Ophthalmic Packaging Market Snapshot, 2026 and 2033
1.2. Market Opportunity Assessment, 2026-2033, US$ Mn
1.3. Key Market Trends
1.4. Future Market Projections
1.5. Premium Market Insights
1.6. Industry Developments and Key Market Events
1.7. PMR Analysis and Recommendations
2. Market Overview
2.1. Market Scope and Definition
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Opportunity
2.2.4. Challenges
2.2.5. Key Trends
2.3. Product Lifecycle Analysis
2.4. Ophthalmic Packaging Market: Value Chain
2.4.1. List of Raw Material Suppliers
2.4.2. List of Manufacturers
2.4.3. List of Distributors
2.4.4. Profitability Analysis
2.5. Forecast Factors - Relevance and Impact
2.6. Covid-19 Impact Assessment
2.7. PESTLE Analysis
2.8. Porter Five Force’s Analysis
2.9. Geopolitical Tensions: Market Impact
2.10. Regulatory and Application Landscape
3. Macro-Economic Factors
3.1. Global Sectorial Outlook
3.2. Global GDP Growth Outlook
3.3. Global Parent Market Overview
4. Price Trend Analysis, 2020-2033
4.1. Key Highlights
4.2. Key Factors Impacting Product Prices
4.3. Prices By Product Type/Composition/Application
4.4. Regional Prices and Product Preferences
5. Global Ophthalmic Packaging Market Outlook: Historical (2020-2025) and Forecast (2026-2033)
5.1. Key Highlights
5.1.1. Market Size and Y-o-Y Growth
5.1.2. Absolute $ Opportunity
5.2. Market Size (US$ Mn) Analysis and Forecast
5.2.1. Historical Market Size Analysis, 2020-2025
5.2.2. Current Market Size Forecast, 2026-2033
5.3. Global Ophthalmic Packaging Market Outlook: Dose Format
5.3.1. Introduction / Key Findings
5.3.2. Historical Market Size (US$ Mn) and Volume Analysis By Dose Format, 2020-2025
5.3.3. Current Market Size (US$ Mn) and Volume Forecast By Dose Format, 2026-2033
5.3.3.1. Single-Dose
5.3.3.2. Multi-Dose
5.4. Market Attractiveness Analysis: Dose Format
5.5. Global Ophthalmic Packaging Market Outlook: Packaging Type
5.5.1. Introduction / Key Findings
5.5.2. Historical Market Size (US$ Mn) and Volume Analysis By Packaging Type, 2020-2025
5.5.3. Current Market Size (US$ Mn) and Volume Forecast By Packaging Type, 2026-2033
5.5.3.1. Bottles
5.5.3.2. Tubes
5.5.3.3. Vials & Ampoules
5.5.3.4. Syringes/Pre-filled Syringes
5.5.3.5. Other Ophthalmic Containers
5.6. Market Attractiveness Analysis: Packaging Type
6. Global Ophthalmic Packaging Market Outlook: Region
6.1. Key Highlights
6.2. Historical Market Size (US$ Mn) and Volume Analysis By Region, 2020-2025
6.3. Current Market Size (US$ Mn) and Volume Forecast By Region, 2026-2033
6.3.1. North America
6.3.2. Europe
6.3.3. East Asia
6.3.4. South Asia & Oceania
6.3.5. Latin America
6.3.6. Middle East & Africa
6.4. Market Attractiveness Analysis: Region
7. North America Ophthalmic Packaging Market Outlook: Historical (2020-2025) and Forecast (2026-2033)
7.1. Key Highlights
7.2. Pricing Analysis
7.3. Historical Market Size (US$ Mn) and Volume Analysis By Market, 2020-2025
7.3.1. By Country
7.3.2. By Dose Format
7.3.3. By Packaging Type
7.4. Current Market Size (US$ Mn) and Volume Forecast By Country, 2026-2033
7.4.1. U.S.
7.4.2. Canada
7.5. Current Market Size (US$ Mn) and Volume Forecast By Dose Format, 2026-2033
7.5.1. Single-Dose
7.5.2. Multi-Dose
7.6. Current Market Size (US$ Mn) and Volume Forecast By Packaging Type, 2026-2033
7.6.1. Bottles
7.6.2. Tubes
7.6.3. Vials & Ampoules
7.6.4. Syringes/Pre-filled Syringes
7.6.5. Other Ophthalmic Containers
7.7. Market Attractiveness Analysis
8. Europe Ophthalmic Packaging Market Outlook: Historical (2020-2025) and Forecast (2026-2033)
8.1. Key Highlights
8.2. Pricing Analysis
8.3. Historical Market Size (US$ Mn) and Volume Analysis By Market, 2020-2025
8.3.1. By Country
8.3.2. By Dose Format
8.3.3. By Packaging Type
8.4. Current Market Size (US$ Mn) and Volume Forecast By Country, 2026-2033
8.4.1. Germany
8.4.2. France
8.4.3. U.K.
8.4.4. Italy
8.4.5. Spain
8.4.6. Russia
8.4.7. Rest of Europe
8.5. Current Market Size (US$ Mn) and Volume Forecast By Dose Format, 2026-2033
8.5.1. Single-Dose
8.5.2. Multi-Dose
8.6. Current Market Size (US$ Mn) and Volume Forecast By Packaging Type, 2026-2033
8.6.1. Bottles
8.6.2. Tubes
8.6.3. Vials & Ampoules
8.6.4. Syringes/Pre-filled Syringes
8.6.5. Other Ophthalmic Containers
8.7. Market Attractiveness Analysis
9. East Asia Ophthalmic Packaging Market Outlook: Historical (2020-2025) and Forecast (2026-2033)
9.1. Key Highlights
9.2. Pricing Analysis
9.3. Historical Market Size (US$ Mn) and Volume Analysis By Market, 2020-2025
9.3.1. By Country
9.3.2. By Dose Format
9.3.3. By Packaging Type
9.4. Current Market Size (US$ Mn) and Volume Forecast By Country, 2026-2033
9.4.1. China
9.4.2. Japan
9.4.3. South Korea
9.5. Current Market Size (US$ Mn) and Volume Forecast By Dose Format, 2026-2033
9.5.1. Single-Dose
9.5.2. Multi-Dose
9.6. Current Market Size (US$ Mn) and Volume Forecast By Packaging Type, 2026-2033
9.6.1. Bottles
9.6.2. Tubes
9.6.3. Vials & Ampoules
9.6.4. Syringes/Pre-filled Syringes
9.6.5. Other Ophthalmic Containers
9.7. Market Attractiveness Analysis
10. South Asia & Oceania Ophthalmic Packaging Market Outlook: Historical (2020-2025) and Forecast (2026-2033)
10.1. Key Highlights
10.2. Pricing Analysis
10.3. Historical Market Size (US$ Mn) and Volume Analysis By Market, 2020-2025
10.3.1. By Country
10.3.2. By Dose Format
10.3.3. By Packaging Type
10.4. Current Market Size (US$ Mn) and Volume Forecast By Country, 2026-2033
10.4.1. India
10.4.2. Southeast Asia
10.4.3. ANZ
10.4.4. Rest of South Asia & Oceania
10.5. Current Market Size (US$ Mn) and Volume Forecast By Dose Format, 2026-2033
10.5.1. Single-Dose
10.5.2. Multi-Dose
10.6. Current Market Size (US$ Mn) and Volume Forecast By Packaging Type, 2026-2033
10.6.1. Bottles
10.6.2. Tubes
10.6.3. Vials & Ampoules
10.6.4. Syringes/Pre-filled Syringes
10.6.5. Other Ophthalmic Containers
10.7. Market Attractiveness Analysis
11. Latin America Ophthalmic Packaging Market Outlook: Historical (2020-2025) and Forecast (2026-2033)
11.1. Key Highlights
11.2. Pricing Analysis
11.3. Historical Market Size (US$ Mn) and Volume Analysis By Market, 2020-2025
11.3.1. By Country
11.3.2. By Dose Format
11.3.3. By Packaging Type
11.4. Current Market Size (US$ Mn) and Volume Forecast By Country, 2026-2033
11.4.1. Brazil
11.4.2. Mexico
11.4.3. Rest of Latin America
11.5. Current Market Size (US$ Mn) and Volume Forecast By Dose Format, 2026-2033
11.5.1. Single-Dose
11.5.2. Multi-Dose
11.6. Current Market Size (US$ Mn) and Volume Forecast By Packaging Type, 2026-2033
11.6.1. Bottles
11.6.2. Tubes
11.6.3. Vials & Ampoules
11.6.4. Syringes/Pre-filled Syringes
11.6.5. Other Ophthalmic Containers
11.7. Market Attractiveness Analysis
12. Middle East & Africa Ophthalmic Packaging Market Outlook: Historical (2020-2025) and Forecast (2026-2033)
12.1. Key Highlights
12.2. Pricing Analysis
12.3. Historical Market Size (US$ Mn) and Volume Analysis By Market, 2020-2025
12.3.1. By Country
12.3.2. By Dose Format
12.3.3. By Packaging Type
12.4. Current Market Size (US$ Mn) and Volume Forecast By Country, 2026-2033
12.4.1. GCC
12.4.2. South Africa
12.4.3. Northern Africa
12.4.4. Rest of Middle East & Africa
12.5. Current Market Size (US$ Mn) and Volume Forecast By Dose Format, 2026-2033
12.5.1. Single-Dose
12.5.2. Multi-Dose
12.6. Current Market Size (US$ Mn) and Volume Forecast By Packaging Type, 2026-2033
12.6.1. Bottles
12.6.2. Tubes
12.6.3. Vials & Ampoules
12.6.4. Syringes/Pre-filled Syringes
12.6.5. Other Ophthalmic Containers
12.7. Market Attractiveness Analysis
13. Competition Landscape
13.1. Market Share Analysis, 2025
13.2. Market Structure
13.2.1. Competition Intensity Mapping By Market
13.2.2. Competition Dashboard
13.2.3. Apparent Production/Service Capacity
13.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
13.3.1. Gerresheimer AG
13.3.1.1. Overview
13.3.1.2. Segments and Products
13.3.1.3. Key Financials
13.3.1.4. Market Developments
13.3.1.5. Market Strategy
13.3.2. AptarGroup Inc.
13.3.3. Amcor plc
13.3.4. Schott AG
13.3.5. West Pharmaceutical Services Inc.
13.3.6. Berry Global Inc.
13.3.7. Bormioli Pharma S.p.A.
13.3.8. Nolato AB
13.3.9. Vetter Pharma
13.3.10. SGD Pharma
13.3.11. Tekni-Plex Inc.
13.3.12. Recipharm AB
13.3.13. ALPLA Group
13.3.14. Hoffmann Neopac
13.3.15. Nemera
14. Appendix
14.1. Research Methodology
14.2. Research Assumptions
14.3. Acronyms and Abbreviations